Rujieping Asparagus and Bromelains Capsules

1. Indications and Usage
Breast Disorders: Indicated for the treatment of mammary cystic hyperplasia and male gynecomastia.
2. Dosage and Administration
Standard Dose: Oral administration. The usual dosage is 4–6 capsules per dose, three to four times daily.
Administration: Dosage should be adjusted according to the physician’s advice.
3. Mechanism of Action
Asparagus Component: The main ingredient, asparagine, creates biochemical barriers against the growth of malignant cells, helping to prevent the malignant transformation of healthy cells.
Bromelain Component: As a sulfhydryl enzyme, bromelain selectively hydrolyzes fibrin, dissolving fibrin clots obstructing tissues and improving local fluid circulation.
Therapeutic Effect: The combination provides effects of resolving nodules and anti-inflammatory analgesia.
4. Safety and Warnings
Contraindications: Contraindicated in patients with severe hepatic or renal diseases, coagulation dysfunction, or known hypersensitivity to the components.
Precautions: Use with caution in patients with nephritis or gastric ulcers.
Special Populations: Safety data for pregnant and breastfeeding women, children, and the elderly is currently unclear.
5. Adverse Reactions and Clinical Research
Adverse Reactions: Adverse reactions are currently unclear.
Clinical Application: Clinically utilized for its ability to improve local circulation and reduce nodular hyperplasia in breast tissue.
6. Drug Interactions
Interaction Profile: Drug interactions are currently unclear. Caution is advised when combining with other medications.
7. Pharmaceutical Information
Active Ingredients: Asparagus powder (0.25 g per capsule) and Bromelain (15,000 units per capsule).
Appearance: Hard capsules containing brownish-yellow powder.
Storage: Store in a tightly sealed container in a cool, dry place (not exceeding 20°C).